Julian DG, Valentine PA, Miller GGDisturbances of rate, rhythm and conduction in acute myocardial infarction . Am J Med37:915, 1964
2.
Pantridge JFEmergency treatment of cardiac arrhythmias in myocardial infarction , in Scott DB, Julian DG (eds). Lidocaine in the Treatment of Ventricular Arrhythmias . Edinburgh, Scotland , E & S Livingstone, 1971 pp. 77-81
3.
Cobb LA, Hallstrom APCommunity-based cardiopulmonary resuscitation: What have we learned?Ann NY Acad Sci382:333, 1982
4.
Bayes de Luna A., Coumel P., Leclerq JFAmbulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 137 patients. Am Heart J117:151, 1989
5.
Emergency Cardiac Care Committee and Subcommittees AHA.Guidelines for cardiopulmonary resuscitation and emergency cardiac care. JAMA268:222, 1992
6.
Herlitz J., Ekstrom L., Wennerblom B., et al. Lidocaine in out-of-hospital ventricular fibrillation: Does it improve survival? Resuscitation33:199, 1997
7.
Carden NJ, Steinhaus JELidocaine in cardiac resuscitation from ventricular fibrillation. Circ Res4:680, 1956
8.
Lazzara R., Hope RR, El-Sherif N.Effects of lidocaine on hypoxic and ischemic cardiac cells. Am J Cardiol41:872, 1978
9.
Borer JS, Harrison LA, Kent KMBeneficial effect of lidocaine on ventricular electrical stability and spontaneous ventricular fibrillation during experimental myocardial infarction. Am J Cardiol137:860, 1976
10.
Spear JF, Moore EN, Gerstenblith G.Effect of lidocaine on the ventricular fibrillation threshold in the dog during acute ischemia and premature ventricular contractions. Circulation46:65, 1976
11.
Hanyok JJ, Chow Mss, Kluger J., et al. Antifibrillatory effects of high dose bretylium and a lidocaine-bretylium combination during cardiopulmonary resuscitation. Crit Care Med16:691, 1988
12.
Lie RI, Wellens HJ, Van Capellie FJ.Lidocaine in the prevention of primary ventricular fibrillation: A double-blind, randomized study of 212 consecutive patients. N Engl J Med291:1325, 1974
13.
Weaver WD, Fahrenbruch CE, Johnson DD, et al. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation82:2027, 1990
14.
Furberg CDEffect of antiarrhythmic drugs on mortality after myocardial infarction . Am J Cardiol53:23C, 1983
15.
MacMahon S. , Collins R., Peto R., et al. Effects of prophylactic lidocaine in suspected acute myocardial infarction: An overview of results from randomized controlled clinical trials. JAMA260:1910, 1988
16.
Hine LK, Laird N., Hewitt P., et al. Meta-analysis evidence against prophylactic lidocaine in acute myocardial infarction. Arch Intern Med149:2694, 1989
17.
Singh BNRoutine prophylactic administration in acute myocardial infarction. An idea whose time is all but gone?Circulation86:1033, 1992
18.
Antman EM, Berlin JADeclining incidence of ventricular fibrillation in myocardial infarction: Implications for the prophylactic use of lidocaine. Circulation86:764, 1992
19.
TheCardiac Arrhythmia Suppression Trial (CAST) Investigators. Effect of flecainide and encainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med321:406, 1989
20.
Haynes RE, Chinn TL, Copass MK, et al. Comparison of bretylium tosylate and lidocaine in management of out-of-hospital ventricular fibrillation: A randomized clinical trial. Am J Cardiol48:353, 1981
21.
Olson DW, Thompson BM, Darin JC, et al. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system. Ann Emerg Med113:807, 1984
22.
Singh BNAntiarrhythmic drugs: A re-orientation in light of recent developments in the control of disorders of cardiac rhythm. Am J Cardiol81:3D, 1998
23.
Singh BNCurrent antiarrhythmic drugs: An overview of mechanisms of action and clinical utility action and potential clinical utility. J Cardiovasc Electrophysiol10:283, 1999
24.
Yusuf S., Peto R., Lewis J., et al. Beta-blockade during myocardial infarction: an overview of randomized trials. Prog Cardiovasc Dis27:335, 1985
25.
Beta-blocker Heart Attack Trial Research Group.A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA247:1707, 1982
26.
TheMIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. Eur Heart J6:199, 1985
27.
ISIS-1 Collaborative Group.Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1 (First International Study of Infarct Survival)Lancet1:921, 1988
28.
Kendall MJ, Lynch KP, Hjalmarson A., et al. Beta-blockers and sudden cardiac death. Ann Intern Med123:358, 1995
29.
Hjalmarson A.Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Am J Cardiol;80:35J-39J, 1997
30.
Norris RM, Barnaby PF, Brown MA, et al. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet2:883-886, 1984
31.
Ryden L., Arciniego R., Arnonan K.A double-blind trial of metoprolol in acute myocardial infarction. Effects of ventricular tachyarrhythmias. N Engl J Med308:614, 1983
32.
Schwartz PJThe idiopathic long QT interval syndrome: Progress and questions. Am Heart J109:399, 1985
33.
Hallstrom AP , Cobb LA, Yu BH, et al. An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol68:1025, 1991
34.
Chadda K., Goldstein S., Byington R., et al. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation73:5013, 1986
35.
Teerlink JR , Bassie BMBeta-adrenergic blocker mortality trials in congestive heart failure. Am J Cardiol84:94R, 1999
36.
Packer M., Colucci WS, Sackner-Bernstein JD, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Circulation94:2793, 1996
37.
Packer M., Bristow MR, Cohn JNThe effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med1334:1349, 1996
38.
MERIT-HEFT Study Group.Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet353:2001, 1999
39.
CIBIS-II Investigators and Committees.The cardiac insufficiency bisoprolol study II (CIBIS II): A randomized trial . Lancet353:9, 1999
40.
Australia-New Zealand Heart Failure Research Collaborative Group.Randomised, placebo-controlled trial of cardevilol in patients with congestive heart failure due to ischaemic heart disease. Lancet349:375, 1997
41.
Australia-New Zealand Heart Failure Research Collaborative Group.Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation92:212, 1995
42.
Singh B.Antiarrhythmic actions of amiodarone: A profile of a paradoxical agent . Am J Cardiol78:41, 1996
43.
Charlier R.Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors . Br J Pharmacol.39:668-674, 1970
44.
Amiodarone Trials Meta-Analysis Investigators.The effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: Meta-analysis of individual patient data on 6500 patients from randomised trials. Lancet350:1417, 1997
45.
Boutitie F. , Boissel JP, Connolly SJ, et al. Amiodarone Interaction with β-Blockers: Analysis of the merged EMIAT and CAMIAT databases. Circulation99:2268, 1999
46.
Julian DG, Camm AJ, Franglin G., et al. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT . Lancet349:667, 1997
47.
Cairns JA, Connolly SJ, Roberts RJ, et al. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT . Lancet349:675, 1997
48.
Guidelines for advanced life support: A statement by the Advanced Life Support Working Party of the European Resuscitation Council, 1992. Resuscitation24:111, 1992
49.
Scheinman MM , Levine JH, Cannom DS, et al. Intravenous Amiodarone Multicenter Investigative Group. Dose ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias . Circulation92:3264, 1995
50.
Kowey PR, Levine JH, Herre JM, et al. Intravenous Amiodarone Multicenter Investigative Group. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation92:3255, 1995
51.
Kudenchuk PJ , Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med341:871-8, 1999
